Thought leadership Archives - Insights Get the latest news and education from Mayo Clinic Laboratories Tue, 29 Sep 2026 18:26:04 +0000 en-US hourly 1 https://wordpress.org/?v=7.1.2 Dr. Bill Morice explores trends transforming diagnostics https://news.mayocliniclabs.com/2026/10/01/dr-bill-morice-explores-trends-transforming-diagnostics/ https://news.mayocliniclabs.com/2026/10/01/dr-bill-morice-explores-trends-transforming-diagnostics/#respond Thu, 01 Oct 2026 13:00:00 +0000 https://news.mayocliniclabs.com/?p=123430 Dr. Bill Morice explores trends transforming diagnosticsIn a Becker’s Healthcare podcast, Dr. Bill Morice discusses precision medicine, AI, patient expectations, and challenges facing laboratories.

The post Dr. Bill Morice explores trends transforming diagnostics appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2026/10/01/dr-bill-morice-explores-trends-transforming-diagnostics/feed/ 0
When the science moves, the lab moves: A Q&A with Chris Garcia, M.D. https://news.mayocliniclabs.com/2026/09/29/when-the-science-moves-the-lab-moves-a-qa-with-chris-garcia-m-d/ https://news.mayocliniclabs.com/2026/09/29/when-the-science-moves-the-lab-moves-a-qa-with-chris-garcia-m-d/#respond Tue, 29 Sep 2026 13:00:00 +0000 https://news.mayocliniclabs.com/?p=123426 When the science moves, the lab moves: A Q&A with Chris Garcia, M.D.Christopher Garcia, M.D., on why a new generation of therapies puts laboratory medicine at the center of care, and how data and AI can help make sure patients never wait on the diagnostic.

The post When the science moves, the lab moves: A Q&A with Chris Garcia, M.D. appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2026/09/29/when-the-science-moves-the-lab-moves-a-qa-with-chris-garcia-m-d/feed/ 0
Going beyond standard testing to diagnose rare autoimmune skin diseases https://news.mayocliniclabs.com/2026/09/16/going-beyond-standard-testing-to-diagnose-rare-autoimmune-skin-diseases/ https://news.mayocliniclabs.com/2026/09/16/going-beyond-standard-testing-to-diagnose-rare-autoimmune-skin-diseases/#respond Wed, 16 Sep 2026 13:45:00 +0000 https://news.mayocliniclabs.com/?p=123252 Going beyond standard testing to diagnose rare autoimmune skin diseasesSpecialized immunofluorescence testing helps uncover rare autoimmune blistering diseases, identify underlying cancers, and guide precise treatment, improving diagnostic accuracy and outcomes for patients with challenging skin disorders.

The post Going beyond standard testing to diagnose rare autoimmune skin diseases appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2026/09/16/going-beyond-standard-testing-to-diagnose-rare-autoimmune-skin-diseases/feed/ 0
Mary Jo Williamson discusses strategies for leading teams through change https://news.mayocliniclabs.com/2026/09/10/mary-jo-williamson-discusses-strategies-for-leading-teams-through-change/ https://news.mayocliniclabs.com/2026/09/10/mary-jo-williamson-discusses-strategies-for-leading-teams-through-change/#respond Thu, 10 Sep 2026 14:00:00 +0000 https://news.mayocliniclabs.com/?p=123172 Mary Jo Williamson discusses strategies for leading teams through changeDiscover in a Becker’s Healthcare podcast how leaders can help teams navigate rapid change while staying grounded in mission, strategy, and values.

The post Mary Jo Williamson discusses strategies for leading teams through change appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2026/09/10/mary-jo-williamson-discusses-strategies-for-leading-teams-through-change/feed/ 0
Key Components of Innovation Success https://news.mayocliniclabs.com/2026/08/06/key-components-of-innovation-success/ https://news.mayocliniclabs.com/2026/08/06/key-components-of-innovation-success/#respond Thu, 06 Aug 2026 13:00:00 +0000 https://news.mayocliniclabs.com/?p=122702 Key Components of Innovation SuccessIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Protecting Access to Medicare Act (PAMA) reform and recent reports about the New World screwworm. Dr. Morice also shares insights on building an innovation strategy that delivers meaningful organizational value.

The post Key Components of Innovation Success appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2026/08/06/key-components-of-innovation-success/feed/ 0
Genome-wide methylation profiling brings new clarity to brain tumor diagnosis https://news.mayocliniclabs.com/2026/08/05/genome-wide-methylation-profiling-brings-new-clarity-to-brain-tumor-diagnosis/ https://news.mayocliniclabs.com/2026/08/05/genome-wide-methylation-profiling-brings-new-clarity-to-brain-tumor-diagnosis/#respond Wed, 05 Aug 2026 13:00:00 +0000 https://news.mayocliniclabs.com/?p=122533 Genome-wide methylation profiling brings new clarity to brain tumor diagnosisGenome-wide methylation profiling is transforming the way clinicians approach brain tumor diagnosis. By analyzing epigenetic patterns across the genome, this advanced testing method provides a new level of precision, helping resolve ambiguous cases, reduce diagnostic variability, and support more confident clinical decision-making in complex CNS tumors.

The post Genome-wide methylation profiling brings new clarity to brain tumor diagnosis appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2026/08/05/genome-wide-methylation-profiling-brings-new-clarity-to-brain-tumor-diagnosis/feed/ 0
Expanding access through strategic collaboration: A Q&A with Mary Jo Williamson https://news.mayocliniclabs.com/2026/07/22/expanding-access-through-strategic-collaboration-a-qa-with-mary-jo-williamson/ https://news.mayocliniclabs.com/2026/07/22/expanding-access-through-strategic-collaboration-a-qa-with-mary-jo-williamson/#respond Wed, 22 Jul 2026 12:00:00 +0000 https://news.mayocliniclabs.com/?p=122561 Expanding access through strategic collaboration: A Q&A with Mary Jo WilliamsonAs innovation in clinical diagnostics accelerates, collaboration is becoming increasingly essential to ensure new tools reach the clinicians and patients who need them most. Mary Jo Williamson, chief administrative officer at Mayo Clinic Laboratories, discusses how a strategic approach to collaboration is helping build a more connected diagnostic ecosystem and enabling more comprehensive care.

The post Expanding access through strategic collaboration: A Q&A with Mary Jo Williamson appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2026/07/22/expanding-access-through-strategic-collaboration-a-qa-with-mary-jo-williamson/feed/ 0
What it takes to deliver answers for rare conditions https://news.mayocliniclabs.com/2026/06/29/what-it-takes-to-deliver-answers-for-rare-conditions/ https://news.mayocliniclabs.com/2026/06/29/what-it-takes-to-deliver-answers-for-rare-conditions/#respond Mon, 29 Jun 2026 12:00:00 +0000 https://news.mayocliniclabs.com/?p=122264 What it takes to deliver answers for rare conditionsHow Mayo Clinic Laboratories uses collaboration, data, and global reach to deliver patient-first diagnostic solutions for rare diseases.

The post What it takes to deliver answers for rare conditions appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2026/06/29/what-it-takes-to-deliver-answers-for-rare-conditions/feed/ 0
Phenotype-specific approach transcends traditional testing for autoimmune neurological conditions https://news.mayocliniclabs.com/2026/06/08/phenotype-specific-approach-transcends-traditional-testing-for-autoimmune-neurological-conditions/ https://news.mayocliniclabs.com/2026/06/08/phenotype-specific-approach-transcends-traditional-testing-for-autoimmune-neurological-conditions/#respond Mon, 08 Jun 2026 13:00:00 +0000 https://news.mayocliniclabs.com/?p=121821 Phenotype-specific approach transcends traditional testing for autoimmune neurological conditionsAutoimmune neurology testing has evolved beyond limited paraneoplastic evaluations to phenotype-specific panels that identify clinically relevant antibodies. This phenotype-specific approach significantly improves diagnostic accuracy, reduces false positives, and helps guide faster, more personalized treatment for complex neurological diseases.

The post Phenotype-specific approach transcends traditional testing for autoimmune neurological conditions appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2026/06/08/phenotype-specific-approach-transcends-traditional-testing-for-autoimmune-neurological-conditions/feed/ 0
New assay can detect fusions in 1,445 genes across wide range of tumors https://news.mayocliniclabs.com/2026/04/20/new-assay-can-detect-fusions-in-1445-genes-across-wide-range-of-tumors/ https://news.mayocliniclabs.com/2026/04/20/new-assay-can-detect-fusions-in-1445-genes-across-wide-range-of-tumors/#respond Mon, 20 Apr 2026 13:00:00 +0000 https://news.mayocliniclabs.com/?p=121170 New assay can detect fusions in 1,445 genes across wide range of tumorsNew wtRNA-seq test detects fusions in 1,445 genes with high accuracy, improving cancer diagnosis, treatment decisions, and clinical trial eligibility.

The post New assay can detect fusions in 1,445 genes across wide range of tumors appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2026/04/20/new-assay-can-detect-fusions-in-1445-genes-across-wide-range-of-tumors/feed/ 0